Patent · US Expired

N-[[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]-thioxomethyl and carbonyl]-N-methylglycinamides

US4672059A · kind A · utility

5Cited by
6References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 18, 1985
Grant dateJun 9, 1987
Priority date—
Expiry dateNov 18, 2005

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C327/48
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are tolrestat and oxotolrestat amides and methods of preparation. The amides are new aldose reductase inhibitors useful for the treatment or prevention of diabetic complications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.